ArticleAntibiotics (Basel, Switzerland)2021
Antibacterial Secondary Metabolites from Marine-Derived Fungus
Article in Antibiotics (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
12 citing papers in PubMed, 24 citations in OpenAlex.
- Virtual screening of marine coumarins and xanthenes identifies novel acid-suppressive leads targeting histamine H₂ receptor and gastric proton pump.Biomolecules & biomedicine · 2026Article
- Antibacterial potential of epiphytic fungi obtained from brown algae of Kenyan coastal waters.PloS one · 2026Article
- Penicillides fromMolecules (Basel, Switzerland) · 2024Review
- Antibacterial properties of natural products from marine fungi reported between 2012 and 2023: a review.Archives of pharmacal research · 2024Review
- Significance of research on natural products from marine-derivedFrontiers in microbiology · 2024Review
- Novel citrinin derivatives from fungus Penicillium sp. TW131-64 and their antimicrobial activities.Applied microbiology and biotechnology · 2023Article
- MarineMarine drugs · 2023Review
- Review
- Marine fungal metabolites as a source of drug leads against aquatic pathogens.Applied microbiology and biotechnology · 2022Review
- New Antibacterial Secondary Metabolites from a Marine-DerivedAntibiotics (Basel, Switzerland) · 2022Article
- New Secondary Metabolites from the Marine-Derived FungusMarine drugs · 2022Article
- Beshanzoides A-D, unprecedented cycloheptanone-containing polyketides fromRSC advances · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors at 4 institutions in 1 country.
Funding
Abstract
Four new secondary metabolites, including one
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.